rs11636419
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000761.5(CYP1A2):c.*171A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0875 in 775,572 control chromosomes in the GnomAD database, including 4,835 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.095 ( 932 hom., cov: 29)
Exomes 𝑓: 0.086 ( 3903 hom. )
Consequence
CYP1A2
NM_000761.5 3_prime_UTR
NM_000761.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.143
Publications
12 publications found
Genes affected
CYP1A2 (HGNC:2596): (cytochrome P450 family 1 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.283 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP1A2 | NM_000761.5 | c.*171A>G | 3_prime_UTR_variant | Exon 7 of 7 | ENST00000343932.5 | NP_000752.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP1A2 | ENST00000343932.5 | c.*171A>G | 3_prime_UTR_variant | Exon 7 of 7 | 1 | NM_000761.5 | ENSP00000342007.4 |
Frequencies
GnomAD3 genomes AF: 0.0953 AC: 14391AN: 150984Hom.: 920 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
14391
AN:
150984
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0855 AC: 53409AN: 624480Hom.: 3903 Cov.: 9 AF XY: 0.0929 AC XY: 29381AN XY: 316296 show subpopulations
GnomAD4 exome
AF:
AC:
53409
AN:
624480
Hom.:
Cov.:
9
AF XY:
AC XY:
29381
AN XY:
316296
show subpopulations
African (AFR)
AF:
AC:
2183
AN:
16020
American (AMR)
AF:
AC:
1334
AN:
17490
Ashkenazi Jewish (ASJ)
AF:
AC:
1472
AN:
14154
East Asian (EAS)
AF:
AC:
6262
AN:
30122
South Asian (SAS)
AF:
AC:
12758
AN:
45056
European-Finnish (FIN)
AF:
AC:
2892
AN:
27034
Middle Eastern (MID)
AF:
AC:
212
AN:
2284
European-Non Finnish (NFE)
AF:
AC:
23157
AN:
441212
Other (OTH)
AF:
AC:
3139
AN:
31108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
2102
4204
6306
8408
10510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0955 AC: 14422AN: 151092Hom.: 932 Cov.: 29 AF XY: 0.102 AC XY: 7535AN XY: 73756 show subpopulations
GnomAD4 genome
AF:
AC:
14422
AN:
151092
Hom.:
Cov.:
29
AF XY:
AC XY:
7535
AN XY:
73756
show subpopulations
African (AFR)
AF:
AC:
5336
AN:
41128
American (AMR)
AF:
AC:
1159
AN:
15102
Ashkenazi Jewish (ASJ)
AF:
AC:
357
AN:
3458
East Asian (EAS)
AF:
AC:
1166
AN:
5126
South Asian (SAS)
AF:
AC:
1400
AN:
4724
European-Finnish (FIN)
AF:
AC:
1109
AN:
10410
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3610
AN:
67850
Other (OTH)
AF:
AC:
205
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
587
1174
1760
2347
2934
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1060
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.